Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

From Theory to Therapy: Evaluating Canadian Hemophilia Treatment Centres' Readiness for Gene Therapy Implementation

Roy Khalife, Lindsay Cowley, Alan T. Tinmouth, Lisa D. Duffett, Vanessa Bourck, Alfonso Iorio, Davide Matino, Kay Decker, Karen Strike, David Page, Natasha Pardy, Jerome M. Teitel, Haowei Linda Sun

Blood (2024) 144 (Supplement 1): 3634.

https://doi.org/10.1182/blood-2024-198579

Published: 2024

Journal Articles

Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial

Blood (2024) 144 (Supplement 1): 1053.

https://doi.org/10.1182/blood-2024-208486

Published: 2024

Journal Articles

Use of Fidanacogene Elaparvovec, a Gene Therapy Vector, to Deliver a Stable, Fully Functional Human Factor IX Transgene for the Treatment of Hemophilia B: A Combined Analysis of Safety

Ben Samelson-Jones, Laurent Frenzel, Kaan Kavakli, Adam Cuker, Jerome M. Teitel, Pengling Sun, Lisa J Wilcox, Francesca Biondo, Benjamin Hutter, John McKay, Delphine Agathon, Frank Plonski

Blood (2024) 144 (Supplement 1): 3577.

https://doi.org/10.1182/blood-2024-193453

Published: 2024

Journal Articles

Health-Related Quality of Life in Adults with Hemophilia B after Receiving Gene Therapy with Fidanacogene Elaparvovec

Sylvia von Mackensen, Jonathan M. Ducore, Lindsey A. George, Adam Giermasz, Catherine McGuinn, John E. J. Rasko, Ben J Samelson-Jones, Spencer K. Sullivan, Jerome M. Teitel, Amit Chhabra, Annie F. Fang, Amanda O'Brien, Frank Plonski, Jeremy Rupon, Lynne Smith, Ian Winburn

Blood (2023) 142 (Supplement 1): 3628.

https://doi.org/10.1182/blood-2023-179431

Published: 2023

Journal Articles

Pre-Operative Coagulation Test Results Do Not Correlate with Self-Bleeding Assessment Tool (Self-BAT) Scores

Grace Tang, Rosane Nisenbaum, Rachel Martin, Pauline Manuel, Rebecca Sampat, Jerome M. Teitel, Paula James, Michelle Sholzberg

Blood (2023) 142 (Supplement 1): 2610.

https://doi.org/10.1182/blood-2023-177658

Published: 2023

Journal Articles

Follow-up of More Than 5 Years in a Cohort of Patients with Hemophilia B Treated with Fidanacogene Elaparvovec Adeno-Associated Virus Gene Therapy

Ben J. Samelson-Jones, Spencer K. Sullivan, John E.J. Rasko, Adam Giermasz, Lindsey A. George, Jonathan M. Ducore, Jerome M. Teitel, Catherine E. McGuinn, Amanda O'Brien, Ian Winburn, Lynne M Smith, Amit Chhabra, Jeremy Rupon

Blood (2021) 138 (Supplement 1): 3975.

https://doi.org/10.1182/blood-2021-150541

Published: 2021

Journal Articles

Experience with Continuous Infusion of Recombinant Porcine FVIII in Patients with Acquired Hemophilia a

Daniel Lindsay, Jerome M. Teitel, MD FRCPC, Michelle Sholzberg, MDM, FRCPC, MSc

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-141339

Published: 2020

Journal Articles

"Everything Was Blood When It Comes to Me": Understanding the Lived Experiences of Women with Inherited Bleeding Disorders

Sumedha Arya, MD BSc, Pamela Wilton, RN, CRE, David Page, Laurence Boma-Fischer, PT, MSc, Georgina Floros, RN, Rochelle Winikoff, MD FRCPC, Jerome M. Teitel, MD FRCPC, Katie Dainty, PhD, Michelle Sholzberg, MDBSc,FRCPC,MSc

Blood (2019) 134 (Supplement_1): 5788.

https://doi.org/10.1182/blood-2019-127552

Published: 2019

Journal Articles

Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year

Lindsey A. George, MD, Spencer K. Sullivan, MD, John E.J. Rasko, MBBS, PhD, Adam Giermasz, MD PhD, Benjamin J. Samelson-Jones, MD PhD, Jonathan M. Ducore, MD MPH, Jerome M. Teitel, MD FRCPC, Catherine E. McGuinn, MD, Alexa R. Runowski, MS, Fraser Wright, PhD, Xavier M. Anguela, PhD, Katherine A. High, MD, Denis Rybin, PhD, John E. Murphy, PhD, Jeremy Rupon, MD

Blood (2019) 134 (Supplement_1): 3347.

https://doi.org/10.1182/blood-2019-124091

Published: 2019

Journal Articles

The Frequency and Effect of Baseline Cross-Reacting and De Novo Inhibitors to Recombinant Porcine FVIII in Patients with Congenital and Acquired Hemophilia a

Carolyne Elbaz, MD, Katerina Pavenski, MD, Hina Chaudhry, BSc, Jerome M. Teitel, MD FRCPC, Michelle Sholzberg, MDBSc,FRCPC,MSc

Blood (2019) 134 (Supplement_1): 1128.

https://doi.org/10.1182/blood-2019-122260

Published: 2019

Journal Articles

Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B - 1 Year Follow up and Impact of Baseline Characteristics on Transgene-Derived Factor IX Activity and Persistence

Blood (2017) 130 (Supplement 1): 601.

https://doi.org/10.1182/blood.V130.Suppl_1.601.601

Published: 2017

Journal Articles

Does Age Affect Desmopressin Responsiveness in Patients with Von Willebrand Disease?

Nicola Goldberg, MD, Rosane Nisenbaum, PhD, Hong Song, David Lillicrap, MD FRCPC, Jerome M. Teitel, MD FRCPC, Paula D. James, MD, Michelle Sholzberg, MDM, MSc, FRCPC

Blood (2017) 130 (Supplement 1): 3681.

https://doi.org/10.1182/blood.V130.Suppl_1.3681.3681

Published: 2017

Journal Articles

Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B Achieves Sustained Mean Factor IX Activity Levels of >30% without Immunosuppression

Blood (2016) 128 (22): 3.

https://doi.org/10.1182/blood.V128.22.3.3

Published: 2016

Journal Articles

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

Aditi Khandelwal, MDM, Syed Mahamad, BSc candidate, Jerome M. Teitel, MD, Michelle Sholzberg, MDM, MSc

Blood (2016) 128 (22): 1418.

https://doi.org/10.1182/blood.V128.22.1418.1418

Published: 2016

Journal Articles

An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption

Brett L. Houston, MD, Christine M. Cserti-Gazdewich, MD, Richard Ward, MBBS, Jean St. Louis, MD, Georges E. Rivard, MD, Jerome M. Teitel, MD, Michelle Sholzberg, MD

Blood (2015) 126 (23): 4701.

https://doi.org/10.1182/blood.V126.23.4701.4701

Published: 2015

Journal Articles

Genotype Phenotype Correlation in Patients with aHUS and Abnormal Genetic Studies: A Single Centre Experience

Katerina Pavenski, MD FRCP, Jerome M. Teitel, MD, Gloria Lim, BSc, MSc, MD, Michelle Sholzberg, MD, Michael Kirschfink, Christoph Licht, MD FRCP(C), FASN

Blood (2014) 124 (21): 4186.

https://doi.org/10.1182/blood.V124.21.4186.4186

Published: 2014

Journal Articles

Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends

Irwin Walker, MBBS, Aicha N Traore, MD, MSc, Alfonso Iorio, MD, PhD, Bruce Ritchie, MD, Nancy Heddle, MSc, Kathryn E Webert, MD, MSc, Jean St. Louis, MD, David Lillicrap, MD, Jerome M. Teitel, MD, Anthony K.C. Chan, MBBS, FRCPC, FRCPath

Blood (2012) 120 (21): 1186.

https://doi.org/10.1182/blood.V120.21.1186.1186

Published: 2012

Journal Articles

The Role of ABO Blood Group In TTP Prevalence and Disease Outcome

Katerina Pavenski, MD, FRCP, Jordana Boro, John J. Freedman, MD, FRCPC, Marie B. Garvey, MD, Jerome M. Teitel, MD, FRCPC, Lisa Hicks, MD, MSc, FRCPC

Blood (2010) 116 (21): 4671.

https://doi.org/10.1182/blood.V116.21.4671.4671

Published: 2010

Journal Articles

Apoptotic-Like Events in Bernard-Soulier Syndrome (BSS) Platelets.

Margaret L. Rand, Hong Wang, K.W. Annie Bang, Jerome M. Teitel, Victor S. Blanchette, Alan T. Nurden, John Freedman

Blood (2008) 112 (11): 1235.

https://doi.org/10.1182/blood.V112.11.1235.1235

Published: 2008

NARROW

From Theory to Therapy: Evaluating Canadian Hemophilia Treatment Centres' Readiness for Gene Therapy Implementation

Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial

Use of Fidanacogene Elaparvovec, a Gene Therapy Vector, to Deliver a Stable, Fully Functional Human Factor IX Transgene for the Treatment of Hemophilia B: A Combined Analysis of Safety

Health-Related Quality of Life in Adults with Hemophilia B after Receiving Gene Therapy with Fidanacogene Elaparvovec

Pre-Operative Coagulation Test Results Do Not Correlate with Self-Bleeding Assessment Tool (Self-BAT) Scores

Follow-up of More Than 5 Years in a Cohort of Patients with Hemophilia B Treated with Fidanacogene Elaparvovec Adeno-Associated Virus Gene Therapy

Experience with Continuous Infusion of Recombinant Porcine FVIII in Patients with Acquired Hemophilia a

"Everything Was Blood When It Comes to Me": Understanding the Lived Experiences of Women with Inherited Bleeding Disorders

Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year

The Frequency and Effect of Baseline Cross-Reacting and De Novo Inhibitors to Recombinant Porcine FVIII in Patients with Congenital and Acquired Hemophilia a

Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B - 1 Year Follow up and Impact of Baseline Characteristics on Transgene-Derived Factor IX Activity and Persistence

Does Age Affect Desmopressin Responsiveness in Patients with Von Willebrand Disease?

Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B Achieves Sustained Mean Factor IX Activity Levels of >30% without Immunosuppression

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption

Genotype Phenotype Correlation in Patients with aHUS and Abnormal Genetic Studies: A Single Centre Experience

Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends

The Role of ABO Blood Group In TTP Prevalence and Disease Outcome

Apoptotic-Like Events in Bernard-Soulier Syndrome (BSS) Platelets.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only